T−LAB PRP KIT has been developed to get you a high dose of PRP and used in 1 million+ treatments, exported to 57 countries and used by thousands of doctors around the world.
T-LAB PRP Kit is certified as CE Class IIb certification.
High DEPA Score
*DEPA score data is taken from comparative analyses conducted within the scope of “PRP Classification”, organized by neutral physicians at the IMCAS Congress, which is a congress that world leading PRP producers attend.
We have a lot of followers
but just a T-LAB PRP KIT,
is a T-LAB PRP KIT.
In addition to ISO 13485, it is audited and certified by Lloyd’s Register.
Physicians will now be able to document their use of T-LAB branded products to the patient.
“Among others, PRP obtained with T-Lab PRP Kit reaches the threshold regarding main biological quality criteria we have defined to be used within Remedex centers.”
Dr. Jeremy Magalon
PharmD, PhD / Cell Therapy Department Marseille Public Hospital & University Technical Consultant at Remedex
“I have been in the field of regenerative medicine for many years aiming to enhance the success in the treatment of various approaches in my daily routine. T-LAB products are offering vast benefit, either the easiness of use of its medical devices or obtaining optimum quality for the regenerative derivates such as PRP, BMAC or, SVF. I have my dedicated eagerness to publish further scientific accomplishments of mine which I constantly used T-LAB medical devices.”
Prof. Dr. Alper Ulaşlı
Physical Medicine and Rehabilitation Expert
“I have had the chance to be one of the first doctors in Serbia to use the PRP T-LAB Kit for regenerative and aesthetic purposes. After three years of use, the results are astonishing, firstly, because of the choice of the suitable patients (them having proper indication) and because of the application method. My experience has been backed up by other doctors whom I have trained as KOL to use the T-LAB PRP Kit. So far, I have had over 100 doctors who have passed the training, and no contraindications have been reported so far.”